Knowles Julius's Form 4 filing
Keros Therapeutics, Inc. (KROS) · filed Dec 3, 2021
- Accession no.
- 0001209191-21-067877
- Filed
- Dec 3, 2021
- Trade date
- Dec 1-2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 16 non-derivative transactions. Open-market sales total $2.58M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knowles JuliusCIK 0001808365 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Common Stock | SSaleDisposed | −4,243 | $53.48F2 | −$226,915.64 | 395,014 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −2,766 | $53.48F2 | −$147,925.68 | 267,580 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −5,168 | $54.67F5 | −$282,534.56 | 389,846 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −3,372 | $54.67F5 | −$184,347.24 | 264,208 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −2,528 | $55.71F6 | −$140,834.88 | 387,318 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −1,649 | $55.71F6 | −$91,865.79 | 262,559 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −1,566 | $56.27F7 | −$88,118.82 | 385,752 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −1,021 | $56.27F7 | −$57,451.67 | 261,538 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −79 | $51.99F8 | −$4,107.21 | 385,673 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −52 | $52.00F8 | −$2,704 | 261,486 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −6,372 | $53.17F9 | −$338,799.24 | 379,301 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −4,155 | $53.17F9 | −$220,921.35 | 257,331 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −8,747 | $53.86F10 | −$471,113.42 | 370,554 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −5,705 | $53.86F10 | −$307,271.3 | 251,626 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −138 | $54.67F11 | −$7,544.46 | 370,416 | Indirect | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −90 | $54.67F11 | −$4,920.3 | 251,536 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.04 to $54.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10) and (11).
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.055 to $55.05 inclusive.
Referenced by the price of 2 transactions in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.055 to $56.05 inclusive.
Referenced by the price of 2 transactions in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.06 to $57.02 inclusive.
Referenced by the price of 2 transactions in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.58 to $52.57 inclusive.
Referenced by the price of 2 transactions in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.61 to $53.605 inclusive.
Referenced by the price of 2 transactions in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.625 to $54.43 inclusive.
Referenced by the price of 2 transactions in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.665 to $54.69 inclusive.
Referenced by the price of 2 transactions in Table I.